$2.37
-0.10 (-4.05%)
Open$2.47
Previous Close$2.47
Day High$2.47
Day Low$2.11
52W High$28.44
52W Low$21.76
Volume—
Avg Volume734.8K
Market Cap25.27M
P/E Ratio—
EPS$0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
6 analysts
Price Target
+1,048.5% upside
Current
$2.37
$2.37
Target
$27.22
$27.22
$16.99
$27.22 avg
$37.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.66M | 4.38M | 4.18M |
| Net Income | -1,334,716 | -1,275,702 | -1,196,723 |
| Profit Margin | -28.7% | -29.1% | -28.6% |
| EBITDA | -1,998,989 | -1,970,058 | -1,901,119 |
| Free Cash Flow | -1,162,960 | -1,043,157 | -876,007 |
| Rev Growth | -9.1% | +7.3% | +19.1% |
| Debt/Equity | 0.30 | 0.26 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |